
MATRIX METALLOPROTEINASE: AN OVERVIEW
Abstract
Full Text:
PDFReferences
Baker, A.H., Edward, D.R, Murphy, G. (2002). Metalloproteinase inhibitors: biological actions and therapeutic apportunities. J Cell Sci. 115: 3719-3227.
Benbow, U., Brinckerhoff, C. E. (1997). The AP-1 site and MMP gene regulation: What isall the fuss about?. Matrix Biology 15: 519-526.
Egeblad, M., Werb, Z. (2002). New functions for the matrix metalloproteinase in cancer progression. Nat. Rev. Cancer 2: 161-174
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Research 58, 1048–1051.
Johanne,M.P., Welsch, D.J., Pelletier, J.P. (2001). Metalloproteinases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15: 805-829.
Karin, M., Liu, Z.G., Zandi, E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246.
Klein, G., Vellenga, E., M.W. Fraaije, Kamps, W.A., De Bont, E.S.J.M. (2004). The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukamia. Crit Rev Oncol Hematol 50: 87-100.
Liotta, L.A., Paweletz, C.P. (2001). Invasion and metastasis.The cancer handbook, Nature publishing group p225-234.
Mook, O. R.F., Frederiks, W. M., Van Noorden, C. J.F. (2004). The role of gelatinase in colorectal cancer progression and metastasis. Biochimi Biophys Acta 1705, 69-89.
Nelson, A.R., Fingleton, B., Rotherberg, M.L. and Matrisian, L.M. (2000) Matrix metalloproteinases: biological activity and clinical implications. J. Clin Oncol 18, 1135–1149.
Overall, C.M., López-Otín, C. (2002). Strategies for MMP inhibition in cancer: inovations for the post trial era. Nat Rev Cancer 2: 657-672
Risto, A.A, Kahari, V.M. (2005). Collagenase in cancer. Biochimie 87: 273-286.
Springman, E.B., Angleton, E.L., Birkedal-Hansen, H., Van Wart, H.E., 1990. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A. 87:364-368
Sternlicht, M.D., Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
Van Wart, H.E., Birkedal-Hansen, H. (1990). The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Nalt. Acad. Sci. 87:5578-5582.
Zhang, L., Shi, J., Feng, J., Klocker, H., Lee, C., Zhang, J. (2004). Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer and Prostatic Diseases 7: 327-332
Refbacks
- There are currently no refbacks.